These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8732467)

  • 1. Management of hormone replacement therapy: the Italian experience.
    Crosignani PG
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S13-5. PubMed ID: 8732467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prescription of hormone replacement therapy in Spain: differences between general practitioners and gynaecologists.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S
    Maturitas; 2006 Nov; 55(4):308-16. PubMed ID: 16730140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HRT management: the American experience.
    Carr BR
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S17-20. PubMed ID: 8732468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Swedish gynecologists' and general practitioners' views on the climacteric period: knowledge, attitudes and management strategies.
    Andersson K; Pedersen AT; Mattsson LA; Milsom I
    Acta Obstet Gynecol Scand; 1998 Oct; 77(9):909-16. PubMed ID: 9808379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientific evidence changes prescribing practice--a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003.
    Thunell L; Milsom I; Schmidt J; Mattsson LA
    BJOG; 2006 Jan; 113(1):15-20. PubMed ID: 16398765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of hormone replacement therapy use in Italian women, 1992-1996.
    Chiaffarino F; Parazzini F; La Vecchia C; Bianchi MM; Benzi G; Ricci E; Chiantera V
    Maturitas; 1999 Oct; 33(2):107-15. PubMed ID: 10597874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hormone replacement therapy: the Swedish experience.
    Mattsson LA; Stadberg E; Milsom I
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S3-5. PubMed ID: 8732465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy: changes in frequency and type of prescription by Dutch GPs during the last decade of the millennium.
    Donker GA; Spreeuwenberg P; Bartelds AI; van der Velden K; Foets M
    Fam Pract; 2000 Dec; 17(6):508-13. PubMed ID: 11120723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
    Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
    Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
    Moorhead T; Hannaford P; Warskyj M
    Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the benefits of taking hormone replacement therapy with other prescription drugs.
    Jacobs PA; Hyland ME
    Maturitas; 2003 Dec; 46(4):273-81. PubMed ID: 14625124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician specialty is significantly associated with hormone replacement therapy use.
    Levy BT; Ritchie JM; Smith E; Gray T; Zhang W
    Obstet Gynecol; 2003 Jan; 101(1):114-22. PubMed ID: 12517655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on the use of medication for climacteric complaints in western Europe--II.
    Oddens BJ; Boulet MJ; Lehert P; Visser AP
    Maturitas; 1994 May; 19(1):1-12. PubMed ID: 7935027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy: patterns of use studied through British general practice computerized records.
    Lawrence M; Jones L; Lancaster T; Daly E; Banks E
    Fam Pract; 1999 Aug; 16(4):335-42. PubMed ID: 10493702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and previous use of oral contraceptives among Swedish women.
    Hammar M; Brynhildsen J; Dabrosin L; Frisk J; Lindgren R; Nedstrand E; Wyon Y
    Maturitas; 1996 Nov; 25(3):193-9. PubMed ID: 8981336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45-60 years.
    Groeneveld FP; Bareman FP; Barentsen R; Dokter HJ; Drogendijk AC; Hoes AW
    Maturitas; 1994 Dec; 20(2-3):81-9. PubMed ID: 7715478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has the climacteric been medicalized? A study on the use of medication for climacteric complaints in four countries.
    Oddens BJ; Boulet MJ; Lehert P; Visser AP
    Maturitas; 1992 Dec; 15(3):171-81. PubMed ID: 1465031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.